eli lilly phase 3 trial retatrutide ESC 2024: improves lipid and cardiovascular risk profile in II A Study of Retatrutide (LY3437943)

11 Importantly, structural modifications to GLP-1RAs can prolong their half-life to 5-7 days compared to the 1-5 minute long half-life of endogenous GLP-1

Questions to Ask Your Doctor Given my weight loss goals, is a GLP-1 a good fit for me

[DOI] [PubMed] [Google Scholar] 68.Zhou Y, et al

Does insulin explain the relation between maternal obesity and poor lactation outcomes

doi: 10.1097/00007611-198110000-00009

"This finding suggests that the standard fasting guidelines should suffice to mitigate any risks." The study's findings challenge the current seven-day hold recommendation, particularly for patients using GLP-1 agonists for diabetes management